Abstract
Purpose
Fecal occult blood testing (FOBT) is a pragmatic screening option for many community health centers (CHCs), but FOBT screening programs will not reduce mortality if patients with positive results do not undergo diagnostic colonoscopy (DC). This study was conducted to investigate DC completion among CHC patients.
Methods
This retrospective cohort study used data from three CHCs in the Midwest and Southwest. The primary study outcome was DC completion within 6 months of positive FOBT among adults age 50–75. Patient data was collected using automated electronic queries. Manual chart reviews were conducted if queries produced no evidence of DC. Poisson regression models described adjusted relative risks (RRs) of DC completion.
Results
The study included 308 patients; 63.3 % were female, 48.7 % were Spanish speakers and 35.7 % were uninsured. Based on combined query and chart review findings, 51.5 % completed DC. Spanish speakers were more likely than English speakers to complete DC [RR 1.19; 95 % confidence interval (CI) 1.04–1.36; P = 0.009], and DC completion was lower among patients with 0 visits than those with 1–2 visits (RR 2.81; 95% CI 1.83–4.33; P < 0.001) or ≥3 visits (RR 3.06; 95% CI 1.57–5.95; P = 0.001).
Conclusions
DC completion was low overall, which raises concerns about whether FOBT can reduce CRC mortality in practice. Further research is needed to understand whether CHC navigator programs can achieve very high DC rates. If organizations use FOBT as their primary CRC screening approach and a substantial number of patients receive positive results, both screening rates and DC rates should be measured.
Similar content being viewed by others
References
Yang DX, Gross CP, Soulos PR, Yu JB (2014) Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009. Cancer 120(18):2893–2901. doi:10.1002/cncr.28794
Liss DT, Baker DW (2014) Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care. Am J Prev Med 46(3):228–236
Health Resources and Services Administration 2012 Health Center Data. http://bphc.hrsa.gov/uds/datacenter.aspx?year=2012. Accessed 4 February 2015
Klabunde CN, Joseph DA, King JB, White A, Plescia M (2013) Vital signs: colorectal cancer screening test use—United States, 2012. MMWR Morb Mortal Wkly Rep 62(44):881–888
Fisher JA, Fikry C, Troxel AB (2006) Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines. Cancer Epidemiol Biomark Prev 15(1):108–113. doi:10.1158/1055-9965.EPI-05-0198
Sarfaty M, Doroshenk M, Hotz J, Brooks D, Hayashi S, Davis TC, Joseph D, Stevens D, Weaver DL, Potter MB, Wender R (2013) Strategies for expanding colorectal cancer screening at community health centers. CA Cancer J Clin 63(4):221–231. doi:10.1002/caac.21191
Hoffman RM, Steel S, Yee EF, Massie L, Schrader RM, Murata GH (2010) Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. Prev Med 50(5–6):297–299. doi:10.1016/j.ypmed.2010.03.010
Liles EG, Perrin N, Rosales AG, Feldstein AC, Smith DH, Mosen DM, Schneider JL (2012) Change to FIT increased CRC screening rates: evaluation of a US screening outreach program. Am J Manag Care 18(10):588–595
Baker DW, Brown T, Buchanan DR et al (2014) Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: A randomized clinical trial. JAMA Intern Med 174(8):1235–1241. doi:10.1001/jamainternmed.2014.2352
Gupta S, Halm EA, Rockey DC, Hammons M, Koch M, Carter E, Valdez L, Tong L, Ahn C, Kashner M, Argenbright K, Tiro J, Geng Z, Pruitt S, Sugg Skinner C (2013) Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. doi:10.1001/jamainternmed.2013.9294
Coronado GD, Vollmer WM, Petrik A, Taplin SH, Burdick TE, Meenan RT, Green BB (2014) Strategies and opportunities to STOP colon cancer in priority populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials 38(2):344–349. doi:10.1016/j.cct.2014.06.006
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328(19):1365–1371. doi:10.1056/NEJM199305133281901
Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348(9040):1467–1471. doi:10.1016/S0140-6736(96)03430-7
Green BB, Anderson ML, Wang CY, Vernon SW, Chubak J, Meenan RT, Fuller S (2014) Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med 27(6):789–795. doi:10.3122/jabfm.2014.06.140125
Rao SK, Schilling TF, Sequist TD (2009) Challenges in the management of positive fecal occult blood tests. J Gen Intern Med 24(3):356–360. doi:10.1007/s11606-008-0893-5
Kistler CE, Kirby KA, Lee D, Casadei MA, Walter LC (2011) Long-term outcomes following positive fecal occult blood test results in older adults: benefits and burdens. Arch Intern Med 171(15):1344–1351. doi:10.1001/archinternmed.2011.206
Baig N, Myers RE, Turner BJ, Grana J, Rothermel T, Schlackman N, Weinberg DS (2003) Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol 98(9):2078–2081. doi:10.1111/j.1572-0241.2003.07575.x
Miglioretti DL, Rutter CM, Bradford SC, Zauber AG, Kessler LG, Feuer EJ, Grossman DC (2008) Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Med Care 46(9 Suppl 1):S91–S96. doi:10.1097/MLR.0b013e31817946c8
Raich PC, Whitley EM, Thorland W, Valverde P, Fairclough D (2012) Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population. Cancer Epidemiol Biomark Prev 21(10):1629–1638. doi:10.1158/1055-9965.EPI-12-0513
Baker DW, Liss DT, Alperovitz-Bichell K, Brown T, Carroll JE, Crawford P, Harigopal P, Henley E, Nelson CA, Rittner SS (2015) Colorectal Cancer Screening Rates at Community Health Centers that Use Electronic Health Records: a cross sectional study. J Health Care Poor Underserved 26(2):377–390. doi:10.1353/hpu.2015.0030
Nadel MR, Shapiro JA, Klabunde CN, Seeff LC, Uhler R, Smith RA, Ransohoff DF (2005) A national survey of primary care physicians’ methods for screening for fecal occult blood. Ann Intern Med 142(2):86–94. doi:10.7326/0003-4819-142-2-200501180-00007
List of ICD-9-CM Codes by Chronic Disease Category. Nine Chronic Conditions used in The Dartmouth Atlas of Health Care 2008. March 3, 2008. http://www.dartmouthatlas.org/downloads/methods/chronic_disease_codes_2008.pdf. Accessed 24 February 2015
Zou GY, Donner A (2011) Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. doi:10.1177/0962280211427759
Van Meurs KP, Wright LL, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, Perritt R, Higgins RD, Oh W, Hudak ML, Laptook AR, Shankaran S, Finer NN, Carlo WA, Kennedy KA, Fridriksson JH, Steinhorn RH, Sokol GM, Konduri GG, Aschner JL, Stoll BJ, D’Angio CT, Stevenson DK (2005) Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med 353(1):13–22. doi:10.1056/NEJMoa043927
Bah EI, Lamah MC, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, Shindo N, Fischer WA 2nd, Lamontagne F, Saliou SM, Bausch DG, Moumie B, Jagatic T, Sprecher A, Lawler JV, Mayet T, Jacquerioz FA, Mendez Baggi MF, Vallenas C, Clement C, Mardel S, Faye O, Faye O, Soropogui B, Magassouba N, Koivogui L, Pinto R, Fowler RA (2015) Clinical presentation of patients with Ebola virus disease in Conakry. Guinea. N Engl J Med 372(1):40–47. doi:10.1056/NEJMoa1411249
Diggle P, Heagerty P, Liang K, Zeger S (2002) Analysis of longitudinal data, 2nd edn. Oxford University Press, Norfolk
Percac-Lima S, Lopez L, Ashburner JM, Green AR, Atlas SJ (2014) The longitudinal impact of patient navigation on equity in colorectal cancer screening in a large primary care network. Cancer 120(13):2025–2031. doi:10.1002/cncr.28682
Ko LK, Reuland D, Jolles M, Clay R, Pignone M (2014) Cultural and linguistic adaptation of a multimedia colorectal cancer screening decision aid for Spanish-speaking Latinos. J Health Commun 19(2):192–209. doi:10.1080/10810730.2013.811325
Goldman SN, Liss DT, Brown T, Lee JY, Buchanan DR, Balsley K, Cesan A, Weil J, Garrity BH, Baker DW (2015) Comparative effectiveness of multifaceted outreach to initiate colorectal cancer screening in Community Health Centers: a randomized controlled trial. J Gen Intern Med 30(8):1178–1184. doi:10.1007/s11606-015-3234-5
Shahidi NC, Homayoon B, Cheung WY (2013) Factors associated with suboptimal colorectal cancer screening in US immigrants. Am J Clin Oncol 36(4):381–387. doi:10.1097/COC.0b013e318248da66
Heitman SJ, Ronksley PE, Hilsden RJ, Manns BJ, Rostom A, Hemmelgarn BR (2009) Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 7(12):1272–1278. doi:10.1016/j.cgh.2009.05.032
National Quality Forum: NQF-Endorsed Measures (QPS) (2014) Colorectal Cancer Screening (COL). http://www.qualityforum.org/Measures_Reports_Tools.aspx. Accessed 2 February 2015
Wagner EH, Austin BT, Von Korff M (1996) Organizing care for patients with chronic illness. Milbank Q 74(4):511–544
Lin CJ, Schwaderer KA, Morgenlander KH, Ricci EM, Hoffman L, Martz E, Cosgrove RH, Heron DE (2008) Factors associated with patient navigators’ time spent on reducing barriers to cancer treatment. J Natl Med Assoc 100(11):1290–1297
Doty M, Abrams M, Hernandez S, Stremikis K, Beal A (2010) Enhancing the Capacity of Community Health Centers to Achieve High Performance: Findings from the 2009 Commonwealth Fund National Survey of Federally Qualified Health Centers. The Commonwealth Fund
Cook NL, Hicks LS, O’Malley AJ, Keegan T, Guadagnoli E, Landon BE (2007) Access to specialty care and medical services in community health centers. Health Aff (Millwood) 26(5):1459–1468. doi:10.1377/hlthaff.26.5.1459
Lewis VA, Colla CH, Schoenherr KE, Shortell SM, Fisher ES (2014) Innovation in the safety net: integrating community health centers through accountable care. J Gen Intern Med 29(11):1484–1490. doi:10.1007/s11606-014-2911-0
Acknowledgments
We thank the following individuals for collecting manual chart review data at each participating community health center: Michelle Johnson, MPH at PCC Community Wellness; Regina Knight at North Country HealthCare, and; Devin Gosberry and Elizabeth Schrier at Erie Family Health Center.
Funding
Funding support was provided by the Agency for Healthcare Research and Quality (No. P01 HS021141).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Liss, D.T., Brown, T., Lee, J.Y. et al. Diagnostic colonoscopy following a positive fecal occult blood test in community health center patients. Cancer Causes Control 27, 881–887 (2016). https://doi.org/10.1007/s10552-016-0763-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-016-0763-0